Job title:
Postdoctoral researcher to develop antisense therapies for familial Alzheimer’s
Company:
Job description
Offer DescriptionThis work is focused on the specific targeting of clinical mutations that cause dominant inherited Alzheimer’s disease using a unique antisense strategy (ASO). We will couple those ASO to our proprietary blood-brain shuttles to improve brain exposure, improve administration via intravenous instead of intrathecal routes, and decrease toxicity associated with ASO treatment. The candidate will be involved in both the generation and the testing of the ASO constructs and will follow the clinical candidates on their journey from preclinical to clinical application. Additional information may be found in the following selected references:
- De Strooper, B. & Karran, E. New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of gamma-secretases. EMBO J 43, 887-903 (2024).
- Rue, L. et al. Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. Pharmaceutics 15 (2023).
Where to apply WebsiteRequirementsResearch Field Biological sciences Education Level PhD or equivalentResearch Field Chemistry Education Level PhD or equivalentResearch Field Engineering Education Level PhD or equivalentResearch Field Neurosciences Education Level PhD or equivalentLanguages ENGLISH Level ExcellentAdditional InformationBenefits
- An exceptional strong scientific environment
- Possibility to supervise students and technicians and develop an independent research profile
- Access to state-of-the-art infrastructure
- A stimulating, diverse international world-class research environment
- Animal models, expertise in neurodegenerative disorders
- Financial support is available for at least 2 years (renewable one year contract). However, the successful candidate is encouraged to obtain a personal fellowship (Marie-Curie, HFSP, EMBO, or National funding organizations).
- Start date: as soon as possible – the position is available immediately
Eligibility criteriaThe successful candidate:
- Should hold a PhD degree in neuroscience, biology, chemistry, engineering or a related field
- Should be creative, enthusiastic, critically thinking, and motivated
- Ready to work against stringent deadlines
- Enjoys teamwork and has excellent oral and written communication skills in English.
Appreciated
- Experience working with laboratory mice (FELASA B)
- Project management and effective communication skills
- Knowledge of the literature on neurodegenerative disorders
- Good understanding of antisense oligonucleotide therapies
- Interested in brain delivery of drugs
- Good publication record
Selection processMotivated candidates with a strong interest in neurodegeneration and with a strong commitment to basic research are invited to apply. Please complete the online application procedure and include a CV, a list of publications, a summary of past research and the contact information of 2 to 3 referees. The best-ranked candidates will be invited for an interview.
For additional information concerning this position, please contact Bart De Strooper ( ) or Maarten Dewilde ( )
You can apply for this job no later than 29/11/2024 via theWork Location(s)Number of offers available 1 Company/Institute KU Leuven Country Belgium State/Province Vlaams Brabant City Leuven Postal Code 3000 Street Leuven GeofieldContact State/ProvinceLeuven CityVlaams Brabant StreetLeuven Postal Code3000 E-Mail[email protected]STATUS: EXPIREDShare this page
Expected salary
Location
Louvain, Brabant Flamand
Job date
Fri, 01 Nov 2024 06:33:10 GMT
To help us track our recruitment effort, please indicate in your email/cover letter where (vacanciesineu.com) you saw this job posting.
